Zai Lab (ZLAB) Times Interest Earned (2020 - 2026)
Zai Lab (ZLAB) posted Times Interest Earned of -$42.39 for Q1 2026, down 1200.16% sequentially from -$3.26 in Q4 2025, and up 10.65% YoY from -$38.3 in Q1 2025.
Analysis
Zai Lab (ZLAB) Times Interest Earned (2020 - 2026) Analysis & Trends
Zai Lab has reported Times Interest Earned for 9 years, with the latest figure at -$42.39 in Q1 2026.
- Quarterly Times Interest Earned rose 10.65% year-over-year to -$42.39 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.48 (up 87.6% YoY) and the FY2025 annual result came in at -$0.53, up 25.19% from the prior year.
- Times Interest Earned retreated to -$42.39 in Q1 2026 per ZLAB's latest filing, from -$3.26 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.34 in Q4 2022 and troughed at -$622.2 in Q1 2024.
- A 5-year average of -$101.41 and a median of -$43.5 in 2025 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2025: Times Interest Earned slumped 3785.31% in 2023, then surged 94.79% in 2025.
- Over 5 years, Times Interest Earned stood at -$0.34 in 2022, then plunged by 3785.31% to -$13.31 in 2023, then sank by 370.22% to -$62.57 in 2024, then soared by 94.79% to -$3.26 in 2025, then plunged by 1200.16% to -$42.39 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$42.39, -$3.26, and -$34.87 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 1.42 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -0.08 |
| 10 | Zai Lab | 2.93 Bn | 2.23 Bn | 58.15 Mn | -48.20 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.20 |
| Mar 31, 2026 | -42.39 |
| Dec 31, 2025 | -51.00 |
| Sep 30, 2025 | -34.87 |
| Jun 30, 2025 | -43.50 |
| Mar 31, 2025 | -47.44 |
| Dec 31, 2024 | -75.10 |
| Sep 30, 2024 | -91.08 |
| Jun 30, 2024 | -154.60 |
| Mar 31, 2024 | -622.20 |
| Dec 31, 2020 | -3,969.00 |
| Sep 30, 2020 | -1,773.42 |
| Jun 30, 2020 | -1,526.65 |
| Mar 31, 2020 | -785.12 |